The Effect of Fluoxetine in Depression Associated with Multiple Sclerosis

Carter S , Sciarra D , Merritt HH . Course of multiple sclerosis as determined by autopsy proven cases. Res Publ Assoc Res Nerv Ment Dis 1950; 28: 471.

Aring CD . Observations on multiple sclerosis and conversion hysteria. Brain 1965; 88: 663.

O'Mally PP . Severe mental symptoms in disseminated sclerosis: a neuropathological study. J IR Med Assoc 1966; 58: 116.

Kurland LT . The epidemiologic characteristics of multiple sclerosis In: Vinken PJ , Bruyn GW , eds. Handbook of clinical neurology, Volume 9. New York: American Elsevier, 1970.

Chouinard G. A double-blind controlled clinical trial of fluoxetine and amilriptylinc in the treatment of outpatients with major depressive disorder. J Clin Psychiatry 1985; 46(3): 32–37.

Montgomery SA . The benefits and risks of 5-HT uptake inhibitors in depression. Br J Psychiatry 1988; 153(3): 7–10.

Paykel ES , Mueller PS , DeLaVergene PM . Amitriptyline, weight gain and carbohydrate craving: a side effect. Br J Psychiatry 38; 631–636.